Background: Non-invasive, precision monitoring of hepatocellular carcinoma (HCC)
treatment efficacy would greatly facilitate personalized therapy and improve patient …

4103 Background: Hepatocellular carcinoma (HCC) is one of the most common and lethal
cancers worldwide, especially in Asian counties. Patients can be treated more effectively if …

The intricate epigenetic landscape of hepatocellular carcinoma (HCC) is profoundly
influenced by alterations in DNA methylation patterns. Understanding these alterations is …

An effective blood-based method for the diagnosis and prognosis of hepatocellular
carcinoma (HCC) has not yet been developed. Circulating tumour DNA (ctDNA) carrying …

Background: Neoadjuvant chemotherapy (neoCTx) followed by hepatic resection is the
treatment of choice for patients with colorectal cancer liver metastasis (CLM). Treatment …

Background Early diagnosis of hepatocellular carcinoma (HCC) can significantly improve
patient survival. We aimed to develop a blood‐based assay to aid in the diagnosis, detection …

Simple Summary Malignant liver tumors consist of primary tumors and metastases. A correct
diagnosis can be achieved with different methods; one of them is the analysis of the cell-free …

e16245 Background: Minimal residual disease (MRD) is considered an essential factor
leading to early relapse after radical surgery, which is challenging to be detected by …

4600 Background: Hepatocellular carcinoma (HCC) represents the second most common
cause of cancer deaths worldwide.□-fetoprotein (AFP) is the most common serological test …

Importance Detection of molecular residual disease and risk stratification as early as
possible may improve the treatment of patients with cancer. Efficient pragmatic tests are …